The short version
5 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Pentamidine Isethionate
Pentamidine Isethionate · PENTAMIDINE DIISETHIONATE 300 mg/300mg · Injection, Powder, Lyophilized, For Solution · Intramuscular; Intravenous · PAI Holdings, LLC dba PAI Pharma
NDC 00121-1101-02 · 10 VIAL, SINGLE-USE in 1 CARTON / 300 mg in 1 VIAL, SINGLE-USE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill · avg $123.78 per prescription
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- ANDA206666
- TE code
- AP
- Approval date
- Sep 28, 2017
- Patents / exclusivity
- None on file
Shortage history
- Planned discontinuation — Pentamidine Isethionate, Injection, 300 mg/3 mL (NDC 39822-3050-2)Mar 23, 2026
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Pentamidine Isethionate (Injection, Powder, Lyophilized, For Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Fresenius Kabi USA, LLC | PENTAMIDINE ISETHIONATE 300 mg/3mL | Jul 15, 2026 | Sep 2, 2026 |
| Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | PENTAMIDINE ISETHIONATE 300 mg/300mg | Jul 15, 2026 | Sep 2, 2026 |
| PAI Holdings, LLC dba PAI Pharma | PENTAMIDINE DIISETHIONATE 300 mg/300mg | Jul 15, 2026 | Sep 2, 2026 |
| Seton Pharmaceuticals | PENTAMIDINE ISETHIONATE 300 mg/300mg | Jul 15, 2026 | Sep 2, 2026 |
| XGen Pharmaceuticals DJB, Inc. | PENTAMIDINE ISETHIONATE 300 mg/3mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Pentamidine Isethionate — NDC 00121-1101-02," retrieved September 3, 2026, https://drugdashboards.com/drug/00121110102.
Free to cite with attribution — see how the data is put together.